Goeltz II Robert C. 4
4 · Arcus Biosciences, Inc. · Filed Dec 17, 2024
Insider Transaction Report
Form 4
Goeltz II Robert C.
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2024-12-15$16.08/sh−10,099$162,392→ 63,732 total
Footnotes (1)
- [F1]Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy the applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.